Banyu, Maruho Receive NHI Approval for Oral Scabies Medication.
Banyu retains approval for the manufacturing and marketing Stromectol in Japan, but has transfered sales rights to Maruho.
Stromectol joins with glutamatergic chloride ion channels, increasing the permeability of the cell membrane to chloride ions which kills parasites. Presently, no effective oral drug has been introduced to treat scabies, so the addition of oral drug Stromectol Tablets 3mg has been encouraged by the health sector in Japan.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Aug 27, 2006|
|Previous Article:||Shimadzu to Release Compact Materials Strength Testing System.|
|Next Article:||Dainippon Launches Cross-advertising Media Service for Mobile.|